SNHG4 knockdown is associated with increased apoptosis rate, decreased BCL-2, and increased BAX protein expression in ovarian cancer cells; these anti-tumoral effects are reversed following co-inhibition of SNHG4 and miR-98-5p (Liu et al., 2023[73]). Here, SNHG4 is linked to ovarian cancer.